Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Cost of Goods Sold

Apellis Pharmaceuticals Inc Cost of Goods Sold Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Cost of Goods Sold from 2019 to 2019.
Other Income Statement Metrics:
  • Apellis Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $-37m a 42.92% decrease of -16m year over year
  • Apellis Pharmaceuticals Inc Net Income for the quarter ending December 12, 2018 was $-36m a 40.38% decrease of -15m year over year
View Chart On Koyfin